We recently published a list of the 10 Best Strong Buy Stocks To Buy Right Now. In this article, we are going to take a look ...

More than 1,000 health care workers at Crystal Run voted overwhelmingly to unionize, but their employer, Optum, is trying to ...

There were 122 National Labor Relations Board representation elections run in February 2025, and ten involved units of 250 or ...

Find out why it can - but is unsuited to this Manchester United squad. Alejandro Garnacho's bad misses at Tottenham underlined his personal scoring drought - and Ruben Amorim's big problems in ...

UnitedHealth Group stands out as a solid investment choice amidst financial uncertainty. With an equity beta of 0.67, it ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Meet the Health Care Executives of the Year honorees for Atlanta Business Chronicle's Health Care Champion Awards.

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...